The draft Guidelines for prevention of transfusion-associated graft-versus-host disease (TA-GVHD) have been developed by the ANZSBT Clinical Practice Improvement Committee.
These guidelines cover the pathophysiology of TA-GVHD, equipment dosimetry and maintenance, clinical indications for irradiated blood components, alternatives to irradiation and risk-management approaches to patient identification, component selection and modification and inventory management to prevent TA-GVHD.
We invite interested individuals, groups and organisations to comment on the Guidelines and encourage you to advise your colleagues of its availability for public comment.
- The draft Guidelines document for review can be found here: Draft Guidelines for prevention of transfusion associated graft versus host disease (TA-GVHD) July 2022 CONSULTATION VERSION
- The feedback form to annotate your feedback can be found here: ANZSBT Consultation Feedback Sheet
Please provide written feedback by COB Wednesday 31 August 2022. Please submit your feedback by email to anzsbt@anzsbt.org.au